You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Programmed Cell Death Receptor Ligand 1 (PD-L1)

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Metastatic Trial in Guangzhou (Tamoxifen Oral Product)

Completed
Has Results
  • Breast Cancer Metastatic
  • Tamoxifen Oral Product
  • Guangzhou, Guangdong, China
    Sun Yat-sen University, Cancer Center
Mar 25, 2022

Metastatic Colorectal Cancer, RAS Mutation Trial in Hangzhou (sintilimab injection, Control Test)

Recruiting
  • Metastatic Colorectal Cancer
  • RAS Mutation
  • sintilimab injection
  • Control Test
  • Hangzhou, Zhejiang, China
    the Second Affiliated Hospital of Medical College of Zhejiang Un
Apr 19, 2021

Genitourinary Cancer, Adrenocortical Carcinoma, Non-urothelial Bladder Trial in United States (Ipilimumab, Nivolumab)

Recruiting
  • Genitourinary Cancer
  • +7 more
  • La Jolla, California
  • +5 more
Jul 5, 2022

Effect of COVID-19 on Endothelial Function

Recruiting
  • COVID-19
  • Endothelial Dysfunction
    • Patras, Achaia, Greece
      University Hospital of Patras
    Aug 12, 2022

    NSCLC Trial in Hangzhou (sintilimab, pemetrexed, Carboplatin)

    Active, not recruiting
    • Non-small Cell Lung Cancer
    • sintilimab
    • +3 more
    • Hangzhou, Zhejiang, China
      Second Affiliated Hospital, School of Medicine, Zhejiang Univers
    Jul 11, 2022

    Healthy Trial in Baltimore (HNC664 capsules Single dose, HNC664 s Single dose, HNC664 capsules FED)

    Recruiting
    • Healthy
    • HNC664 capsules Single dose
    • +2 more
    • Baltimore, Maryland
      Pharmaron
    Mar 22, 2022

    Metastatic Colorectal Cancer Trial in Tanta (Silymarin)

    Not yet recruiting
    • Metastatic Colorectal Cancer
    • Tanta, Egypt
      faculty of Pharmacy , Tanta University
    Dec 8, 2022

    Prolonged Grief Disorder Trial in New York, Madison (Web Based Therapist Tutorial on Prolonged Grief Disorder Therapy)

    Completed
    • Prolonged Grief Disorder
    • Web Based Therapist Tutorial on Prolonged Grief Disorder Therapy
    • New York, New York
    • +1 more
    Jul 19, 2022

    Non-small-cell Lung Cancer, Mesothelioma Trial in Wuhan (aPD1-MSLN-CAR T cells)

    Recruiting
    • Non-small-cell Lung Cancer
    • Mesothelioma
    • αPD1-MSLN-CAR T cells
    • Wuhan, Hubei, China
      Union Hospital affiliated to Tongji Medical College of Huazhong
    Jul 27, 2020

    Suicide, Attempted Trial (As usual, Protection plan)

    Not yet recruiting
    • Suicide, Attempted
    • As usual
    • Protection plan
    • (no location specified)
    Jan 13, 2023

    Clinical Stage III Cutaneous Melanoma AJCC v8, Melanoma, Metastatic Melanoma Trial in Rochester (Anti-PD-L1 Monoclonal Antibody

    Recruiting
    • Clinical Stage III Cutaneous Melanoma AJCC v8
    • +3 more
    • Anti-PD-L1 Monoclonal Antibody IMC-001
    • Punch Biopsy
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 4, 2023

    Genetic Studies of Lysosomal Storage Disorders

    Enrolling by invitation
    • Lysosomal Storage Disorders
    • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 21, 2023

      Prostate Cancer Trial in Charleston (Simvastatin 40mg)

      Recruiting
      • Prostate Cancer
      • Simvastatin 40mg
      • Charleston, South Carolina
        Hollings Cancer Center at Medical University of South Carolina
      Nov 30, 2022

      Mycobacterium Avium Complex, Non-tuberculous Mycobacterium Pulmonary Disease Trial in United States (SPR720, Placebo, Open-label

      Terminated
      Has Results
      • Mycobacterium Avium Complex
      • Non-tuberculous Mycobacterium Pulmonary Disease
      • Altamonte Springs, Florida
      • +8 more
      Feb 3, 2022

      Analyses of Anemia in Very Low Birth Weight (VLBW) Infants.

      Recruiting
      • Very Preterm Maturity of Infant
      • The Risk Factors for Improving the Prognosis of VLBW Infants
      • No intervention
      • Shenzhen, Guangdong, China
        Shenzhen Bao'an Maternal and Child Health Hospital
      Jul 16, 2023

      Stage III NSCLC Trial in Birmingham (Adaptive Radiotherapy, Non-Adaptive Radiotherapy, Chemotherapy)

      Not yet recruiting
      • Stage III Non-small Cell Lung Cancer
      • Adaptive Radiotherapy
      • +3 more
      • Birmingham, Alabama
        University of Alabama at Birmingham
      Aug 3, 2022

      Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma, Refractory B Acute Lymphoblastic Leukemia Trial in

      Recruiting
      • Recurrent B Acute Lymphoblastic Leukemia
      • +3 more
      • Biospecimen Collection
      • +11 more
      • Birmingham, Alabama
      • +152 more
      Jan 30, 2023

      Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients Trial in Assiut (Quantitative Real Time Polymerase chain

      Recruiting
      • Inflammasome NLRP3 And IL-1B Gene Expression in COVID-19 Patients
      • Quantitative Real Time Polymerase chain reaction (qRT-PCR)
      • ELISA and colorimeter
      • Assiut, Egypt
        Biochemistry department,Faculty of medicine
      Oct 10, 2023

      Hematological Malignancy Trial (Thymoglobulin Injectable Product)

      Not yet recruiting
      • Hematological Malignancy
      • Thymoglobulin Injectable Product
      • (no location specified)
      Sep 27, 2023

      Metastatic Basal Cell Carcinoma, Locally Advanced Basal Cell Carcinoma Trial in Bordeaux (Treatment with vismodegib)

      Completed
      • Metastatic Basal Cell Carcinoma
      • Locally Advanced Basal Cell Carcinoma
      • Treatment with vismodegib
      • Bordeaux, France
        Chu de Bordeaux
      Aug 17, 2022

      Diffuse Large B-cell Lymphoma Trial in Hangzhou (Metabolically Armed CD19 CAR-T cells)

      Recruiting
      • Diffuse Large B-cell Lymphoma
      • Metabolically Armed CD19 CAR-T cells
      • Hangzhou, Zhejiang, China
        The first affiliated hospital of medical college of zhejiang uni
      Nov 1, 2023

      Colon Cancer Trial (Pembrolizumab)

      Not yet recruiting
      • Colon Cancer
      • (no location specified)
      Dec 14, 2022

      Myocardial Fibrosis, Hypertrophic Cardiomyopathy Trial in Boston (Spironolactone, Placebo)

      Completed
      Has Results
      • Myocardial Fibrosis
      • Hypertrophic Cardiomyopathy
      • Boston, Massachusetts
        Tufts Medical Center
      Mar 31, 2021

      Head Neck Cancer Trial in Boston (AMD3100, Pembrolizumab)

      Withdrawn
      • Head and Neck Cancer
      • Boston, Massachusetts
      • +1 more
      Sep 3, 2020

      Chronic Hepatitis b Trial in Hong Kong (RBD1016, Placebo, Entecavir)

      Recruiting
      • Chronic Hepatitis b
      • Hong Kong, China
        The University of Hong Kong
      Apr 24, 2022